What is the name of the drug and what does it do? Hympavzi (pronounced him-PAV-zee), generic name marstacimab-hncq, is a medicine used to reduce or prevent bleeding episodes in people with hemophilia A or B. This treatment is specifically for individuals aged 12 years and older who do not have inhibitors (antibodies) against factor VIII or factor IX. Was Approved on...
What is the name of the drug and what does it do? Orlynvah (pronounced OR-lin-vah), a combination of sulopenem etzadroxil and probenecid, is a medication used to treat uncomplicated urinary tract infections (uUTIs) in adult women. It is specifically prescribed when there are limited or no alternative oral antibiotics available. Orlynvah targets bacterial infections...
Wegovy® has already changed how obesity is treated through a once-weekly injection. Now, Wegovy is entering a new phase. In early January 2026, Wegovy will become the first available daily oral GLP-1 tablet for chronic weight management, offering a pill option alongside the existing injectable form. This approval marks an important step for people who prefer an oral...
What is it prescribed for? REZDIFFRA, approved on March 14, 2024, is indicated in conjunction with diet and exercise for the treatment of adults with noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis. What is the name of the drug and what does it do? Rezdiffra (pronounced rez-DIF-rah), (generic name: resmetirom), is a...
What is it prescribed for? EXBLIFEP, Approved on February 22, 2024, is indicated for the treatment of patients 18 years and older with complicated urinary tract infections (cUTI) including pyelonephritis caused by designated susceptible microorganisms. What is the name of the drug and what does it do? Exblifep (pronounced ex-BLI-fep), (generic name: cefepime and...
What is it prescribed for? Iqirvo,  Approved on June 10, 2024, is indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have an inadequate response to UDCA, or as monotherapy in patients unable to tolerate UDCA. What is the name of the drug and what does it do? Iqirvo (pronounced eye-KER-vo),...